12 research outputs found
High genetic diversity in Campylobacter concisus isolates from patients with microscopic colitis
Campylobacter concisus from chronic inflammatory bowel diseases stimulates IL-8 production in HT-29 cells
<i>Campylobacter concisus</i> is prevalent in the gastrointestinal tract of patients with microscopic colitis
Campylobacter concisus from chronic inflammatory bowel diseases stimulates IL-8 production in HT-29 cells
Abstract The emerging pathogen Campylobacter concisus has been isolated from patients with gastrointestinal diseases; however, it is also present in the gut of healthy individuals. The aim of this study was to compare IL-8 production in HT-29 cells after infection with C. concisus from different gastrointestinal disease phenotypes. Additionally, to investigate whether differentiation of isolates in genomospecies (GS1 and GS2) or presence of the zot gene, encoding the Zot toxin, affects IL-8 production. A total of 37 C. concisus isolates from patients with microscopic colitis (n = 20), ulcerative colitis (n = 5), Crohn’s disease (n = 5), diarrhoea (n = 2) and from healthy controls (n = 5) were used. Intestinal HT-29 cells were infected and incubated for 24 h. Supernatants were subsequently removed and analysed for IL-8 by MILLIPLEX. All isolates were able to stimulate IL-8 production and IL-8 levels were higher than in non-infected HT-29 cells. No difference was observed between disease phenotypes or GS1 and GS2, whereas presence of the zot gene showed a tendency towards higher IL-8 production. Further investigations in other inflammatory and physiological models are needed to conclude whether C. concisus strains from different gastrointestinal disease phenotypes differ in pathogenic potential and play a part in gastrointestinal disease
Campylobacter concisus from chronic inflammatory bowel diseases stimulates IL-8 production in HT-29 cells
Abstract The emerging pathogen Campylobacter concisus has been isolated from patients with gastrointestinal diseases; however, it is also present in the gut of healthy individuals. The aim of this study was to compare IL-8 production in HT-29 cells after infection with C. concisus from different gastrointestinal disease phenotypes. Additionally, to investigate whether differentiation of isolates in genomospecies (GS1 and GS2) or presence of the zot gene, encoding the Zot toxin, affects IL-8 production. A total of 37 C. concisus isolates from patients with microscopic colitis (n = 20), ulcerative colitis (n = 5), Crohn’s disease (n = 5), diarrhoea (n = 2) and from healthy controls (n = 5) were used. Intestinal HT-29 cells were infected and incubated for 24 h. Supernatants were subsequently removed and analysed for IL-8 by MILLIPLEX. All isolates were able to stimulate IL-8 production and IL-8 levels were higher than in non-infected HT-29 cells. No difference was observed between disease phenotypes or GS1 and GS2, whereas presence of the zot gene showed a tendency towards higher IL-8 production. Further investigations in other inflammatory and physiological models are needed to conclude whether C. concisus strains from different gastrointestinal disease phenotypes differ in pathogenic potential and play a part in gastrointestinal disease
High genetic diversity in Campylobacter concisus isolates from patients with microscopic colitis
Abstract The emerging intestinal pathogen Campylobacter concisus has been associated with prolonged diarrhoea and classic inflammatory bowel diseases (IBD) and was recently also linked with microscopic colitis (MC). Previous reports have observed a high genetic diversity within isolates from diarrhoeic and IBD patients and from healthy controls (HC), and division of isolates into two major genomospecies (GS1 and GS2). The aim of this study was to describe genetic diversity in 80 recently cultivated MC biopsy and faecal isolates of C. concisus by multi-locus sequence typing (MLST); and to compare the phylogenetic relatedness to 102 isolates from diarrhoeic and IBD patients and HCs by k-mer-based distance estimation. MLST revealed high genetic diversity in MC isolates with 72 novel sequence types. K-mer divided MC isolates into two distinct clusters (cluster 1 n = 21, cluster 2 n = 49), with a significantly higher prevalence of cluster 2 isolates in biopsies than in faeces, p = 0.009. K-mer divided the 182 isolates into two major phylogenetic clusters: cluster 1 (GS1 isolates) and cluster 2 (GS2 isolates), which further differentiated into three subgroups. Cluster 1 and the three cluster 2 subgroups were each distinctive in mean genome size and GC count. Isolates from all disease phenotypes were present in cluster 1 and cluster 2 subgroup 2 and 3, whereas cluster 2 subgroup 1 only contained isolates restricted to patients with ulcerative colitis (n = 10) and HC (n = 4)
Additional file 2 of High genetic diversity in Campylobacter concisus isolates from patients with microscopic colitis
Additional file 2: Figure S1. Circular tree based on k-mer distance estimation revealed two distinct clusters: cluster 1 and cluster 2. Cluster 2 isolates further differentiated into three subgroups. Cluster 1 (from AAUH_7CCFec@ to AAUH_12CDo) contained 52 GS1 isolates and the reference genome ATCC 33237. Cluster 2 subgroup 1 (from AAUH_44sig@ to AAUH_20HCsig@) contained 14 GS2 isolates and the reference genome 13826. Cluster 2 subgroup 2 (from AAUH_31CCRec1@ to AAUH_40UCf) contained 50 GS2 isolates. Cluster 2 subgroup 3 (from AAUH_27CCSigP3@ to AAUH_16UCdp5) contained 64 GS2 isolates. Branches indicate origin of the isolates: MC (blue) and isolates from Kirk et al. [18] and the reference genomes (yellow)
Additional file 1 of High genetic diversity in Campylobacter concisus isolates from patients with microscopic colitis
Additional file 1: Table S1. Presentation of each MC C. concisus genome used for MLST analysis and k-mer distance estimation (n = 80). Information includes clinical data, isolate origin, GS data and ST